Pallas Capital Advisors LLC Sells 43,485 Shares of DENTSPLY SIRONA Inc. $XRAY

Pallas Capital Advisors LLC lessened its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 52.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 39,036 shares of the medical instruments supplier’s stock after selling 43,485 shares during the period. Pallas Capital Advisors LLC’s holdings in DENTSPLY SIRONA were worth $446,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Mitsubishi UFJ Trust & Banking Corp boosted its stake in DENTSPLY SIRONA by 1,836.7% during the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock valued at $1,344,000 after purchasing an additional 100,468 shares during the last quarter. Commonwealth Equity Services LLC increased its holdings in shares of DENTSPLY SIRONA by 38.4% in the 3rd quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock worth $10,215,000 after purchasing an additional 223,339 shares in the last quarter. CWM LLC raised its stake in shares of DENTSPLY SIRONA by 84.3% in the third quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock worth $5,336,000 after purchasing an additional 192,373 shares during the last quarter. Invenomic Capital Management LP raised its stake in shares of DENTSPLY SIRONA by 48.7% in the third quarter. Invenomic Capital Management LP now owns 4,351,199 shares of the medical instruments supplier’s stock worth $55,217,000 after purchasing an additional 1,425,637 shares during the last quarter. Finally, Advisors Asset Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 42.8% during the third quarter. Advisors Asset Management Inc. now owns 348,989 shares of the medical instruments supplier’s stock valued at $4,429,000 after purchasing an additional 104,588 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,000 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were acquired at an average cost of $12.45 per share, with a total value of $186,750.00. Following the completion of the acquisition, the director directly owned 65,000 shares in the company, valued at $809,250. The trade was a 30.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director James D. Forbes acquired 5,000 shares of the company’s stock in a transaction dated Monday, March 9th. The stock was acquired at an average cost of $12.48 per share, with a total value of $62,400.00. Following the purchase, the director owned 10,000 shares of the company’s stock, valued at approximately $124,800. This trade represents a 100.00% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have acquired 70,000 shares of company stock worth $956,437. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $11.60 on Wednesday. The company has a current ratio of 1.51, a quick ratio of 1.03 and a debt-to-equity ratio of 1.50. DENTSPLY SIRONA Inc. has a 12 month low of $9.85 and a 12 month high of $17.18. The stock has a market cap of $2.32 billion, a price-to-earnings ratio of -3.87, a PEG ratio of 1.32 and a beta of 0.97. The company’s 50 day moving average is $12.54 and its two-hundred day moving average is $12.17.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). The firm had revenue of $961.00 million during the quarter, compared to the consensus estimate of $926.40 million. DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.26 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

Analyst Upgrades and Downgrades

XRAY has been the topic of several recent analyst reports. Robert W. Baird increased their price objective on DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a research report on Friday, February 27th. Barclays initiated coverage on shares of DENTSPLY SIRONA in a research note on Monday, December 8th. They set an “underweight” rating and a $12.00 target price on the stock. Mizuho lifted their price target on shares of DENTSPLY SIRONA from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Monday, March 2nd. Bank of America raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $13.00 to $17.00 in a report on Thursday, February 19th. Finally, Barrington Research increased their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a research report on Monday, March 2nd. Three research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $14.42.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.